Lowering the Threshold for Defining Microalbuminuria: Effects of a Lifestyle-metformin Intervention in Obese "Normoalbuminuric" Non-diabetic Subjects

Abstract

UAE of 10-29 mg/day (hyperalbuminuria), below the conventionally used limit to define microalbuminuria, is already associated with a more adverse cardiovascular risk profile, and is exquisitely sensitive to interventions that reduce obesity, BP, and insulin resistance.